KORU Medical Systems Non-GAAP EPS of -0.03 beats by 0.02, revenue of 7M misses by 0.93M
KRMD Stock | USD 3.81 0.15 4.10% |
About 71 percent of all Repro Med's shareholders are curious in acquiring. The analysis of overall sentiment of trading Repro Med Systems stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
Repro |
KORU Medical Systems press release Q3 Non-GAAP EPS of -0.03 beats by 0.02.Revenue of 7M misses by 0.93M.Reducing full year...
Read at seekingalpha.com
Repro Med Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Repro Med Fundamental Analysis
We analyze Repro Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repro Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repro Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Repro Med is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Repro Med Systems Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Repro Med stock to make a market-neutral strategy. Peer analysis of Repro Med could also be used in its relative valuation, which is a method of valuing Repro Med by comparing valuation metrics with similar companies.
Peers
Repro Med Related Equities
MLSS | Milestone Scientific | 26.58 | ||||
POCI | Precision Optics, | 4.72 | ||||
PDEX | Pro Dex | 2.55 | ||||
ATRC | AtriCure | 0.61 | ||||
MMSI | Merit Medical | 0.88 | ||||
UTMD | Utah Medical | 1.21 | ||||
LMAT | LeMaitre Vascular | 1.55 | ||||
INFU | InfuSystems Holdings | 3.24 |
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |